|Bid||0.00 x 800|
|Ask||0.00 x 1400|
|Day's Range||10.86 - 11.43|
|52 Week Range||7.36 - 16.68|
|Beta (5Y Monthly)||0.04|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 01, 2022 - Aug 05, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||22.75|
Subscribe to Yahoo Finance Plus to view Fair Value for KNSA
Cytokinetics (CYTK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) came out with its first-quarter results last week, and we wanted to see...